Serious brain disorders, such as the Alzheimer's Disease (AD), are associated with a marked drop in the levels of important neurotransmitters, such as acetylcholine (ACh). Real time monitoring of such biomarkers can therefore play a critical role in enhancing AD therapies by allowing timely diagnosis, verifications of treatment effectiveness, and developments of new medicines. In this study, we present the first acetylcholine/oxygen hybrid enzymatic fuel cell for the self-powered on site detection of ACh in plasma, which is based on the combination of an enzymatic anode with a Pt cathode. Firstly, an effective acetylcholinesterase immobilized electrode was developed and its electrochemical performance evaluated. Highly porous gold was used as the electrode material, and the enzyme was immobilized via a one step rapid and simple procedure that does not require the use of harsh chemicals or any electrode/enzyme pretreatments. The resulting enzymatic electrode was subsequently used as the anode of a miniature flow-through membrane-less fuel cell and showed excellent response to varying concentrations of ACh. The peak power generated by the fuel cell was 4 nW at a voltage of 260 mV and with a current density of 9 μA cm -2 . The limit of detection of the fuel cell sensor was 10 μM, with an average response time as short as 3 minutes. These exciting results open new horizons for pointof-care Alzheimer diagnosis and provide an attractive potential alternative to established methods that require laborious and time-consuming sample treatments and expensive instruments.
INTRODUCTION
Dementia describes a set of symptoms that include memory loss and difficulties with thinking, problem-solving and language. Worldwide, over 35 million people are currently diagnosed with dementia. This number that is estimated to double every 20 years in aging populations, thus reaching a value of 65.7 million in 2030, and of 115.4 million in 2050 (Prince et al. 2015) . The most common cause of senile dementia is the Alzheimer's disease (AD), with currently over 17 million cases worldwide (Mayeux and Schupf 2011) . AD is characterized by the progressive loss of cognitive function and personality changes. Early detection of AD, as well as the capability to distinguish it from other forms of dementia, is key to plan timely caring actions and help families intervene before the disease becomes too serious. Yet, so far, there are no definitive diagnostic The identification of relevant biomolecules that could act as AD biomarkers, and therefore allow rapid and effective diagnosis of this disease, is of particular relevance. Recent studies have suggested that systemic signs caused by concentration changes of specific biomolecules, which include mostly the Amyloid-β and Tau proteins present in cerebrospinal fluid (CSF) and plasma, can be associated with the progression of AD (Kanai et al. 1998) . A particularly promising route to diagnose AD is, however, represented by the possibility to monitor the levels of neurotransmitters, such as acetylcholine (ACh), in cerebrospinal fluid. ACh is one of the first identified neurotransmitters and is found in the peripheral and central nerve system of the brain (Cannon et al. 2004; Hou et al. 2012) . The role of ACh is to transmit messages from motor nerves to muscles, especially to the heart, bladder and stomach, and ACh is involved in several functions, including cognition, memory and movement (Hasselmo and Sarter 2010; Van der Zee and Luiten 1999) . The dysfunction in ACh regulation in the brain causes neuropsychiatric disorders such as Alzheimer's disease, Parkinson's disease, progressive dementia, Myasthenia
Gravis and schizophrenia (Davis and Berger 1979; Tandon 1999) . Considering the importance of this biomolecule, there is high interest in developing methods for its in vivo quantification (Garris and A 2010) . Real-time monitoring of extra-cellular concentration changes of ACh would in fact allow understanding the function of the nervous system and the association to AD, examining the degeneration of cholinergic neural systems in AD, and evaluating pharmaceuticals that affect cholinergic activity at the single cell level (Mitchell 2004; Nguyen et al. 2010 ).
Nonetheless, current methods to determine ACh levels in body fluids, such as ELISA (Hinman et al. 1986; Kawanami et al. 1984) and microdialysis sampling combined to offline analysis by liquid chromatography with mass spectroscopy detection (Nirogi et al. 2010; Song et al. 2012; Uutela et al. 2005) , are laborious, expensive, slow and not suitable for in situ monitoring.
Electrochemical sensors are capable of fast in situ detection sensors and, therefore, offer a powerful avenue for real time diagnostics that overcomes the drawback of traditional analytical methods (Wilson and Gifford 2005) . In particular, the detection of ACh and its metabolite choline (Ch) has been successfully demonstrated with enzyme-based amperometric sensors.
Depending on the specific target, the sensors use either acetylcholine esterase (AChE) or choline oxidase (ChOx), as well as both enzymes together (Garguilo and Michael 1995; Hou et al. 2012; Mitchell 2004; Wise et al. 2002) . AChE-based sensors have been also suggested for the detection of toxic organophosphorous pesticides that, by inhibiting the activity of this enzyme, lead to toxic levels of acethylcholine in the cells, with severe threat to human health (Cai et al. 2014; Kaur and Srivastava 2015) . reported, such as the tattoo EFC that generates electricity from lactate in sweat (Jia et al. 2013) and the contact lens that uses the glucose in tears as fuel (Reid et al. 2015) . Considering that within a specific range the power generated is proportional to the amount of substrate (the analyte) in the input solution, the most intuitive use of EFCs is as self-powered amperometric sensors for that substrate. By varying the nature of the enzyme(s) employed, several biomarkers of interest could be detected. The majority of the EFCs reported so far, uses the enzymes glucose oxidase and glucose dehydrogenase and focus on the detection of glucose (Ivanov et al. 2010 ).
An EFC embedded into microfluidic follow-channels paper was reported for the detection of the carcinoembryonic antigen (Li et al. 2015) . Successful examples of EFC applications as sensor for the detection of lactate (Katz et al. 2001) , cyanide (Deng et al. 2010) , mercury ion (Wen et al. 2011 ) and cholesterol (Sekretaryova et al. 2014) have also been reported.
The innovative enzymatic fuel cell reported in the present work utilizes at the anode the enzyme acetylcholinesterase (AChE), which is immobilized onto a nanostructured electrode made of a highly porous gold (hPG) coated onto a Pt surface. The use of nanostructured electrode materials is key to improve the enzyme loading and enhance the electrochemical performance of EFCs (Ivanov et al. 2010) . hPG in particular has proven to be an excellent candidate for EFCs, given its large specific surface area, biocompatibility and non-toxicity (du Toit and Di Lorenzo 2014b) . In this study, we used a rapid and simple one-step electrochemical process to immobilise AChE onto hPG that does not require complex or laborious electrode and/or enzyme pre-treatments. The first part of this study focus on investigating the electrochemical performance of the resulting electrode. Subsequently, the enzymatic electrode is tested as the anode of a flow-through membrane-less fuel cell and the current and power output is recorded for a series of ACh concentrations, thus proving its use as online sensor.
EXPERIMENTAL SECTION

Materials
All the chemicals were of analytical reagent grade and were used without further purification.
Acetylcholinesterase from Electrophorus electricus, 500 U, was purchased from Sigma-Aldrich.
The Saturated Calomel Electrode (SCE), used as the reference electrode, was purchased from IJCambria Ltd. Platinum wire (diameter: 0.5 mm) was purchased from Cookson Precious Metals
Ltd. Polydimethylsiloxane (PDMS, Dow Corning Sylgard 184) was purchased from Ellsworth
Adhesives.
All aqueous solutions used were prepared using reverse osmosis purified water. The phosphate buffered saline (PBS) solution was prepared on a weekly basis and consisted of 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4. The pH of the resulting solution was adjusted to a value of 7.4 with the drop-wise addition of HCl or NaOH. Glycine buffer was prepared by mixing 0.01 M of Glycine with 0.1 M of NaCl and by adjusting the pH to 7.4 by drop-wise addition of NaOH and HCl.
All potentiostatically-controlled electrochemical processes were performed using the Autolab PGSTAT128 N (Metrohm, UK) potentiostat. The moulds for the PDMS structures were 3D printed in polylactic acid using a Makerbot Replicator.
Preparation of the electrodes
The electrodes were prepared by electrodepositing a film of highly porous gold (hPG) onto Pt wires via a hydrogen bubbling template, as previously described ( The electrochemical response of both AChE/hPG/Pt and hPG/Pt electrodes to ACh, within the range of 2-2400 g mL -1 , was evaluated by both chronoamperometry (CA) and Square Wave Voltammetry (SWV) in the conventional three-electrode set-up (SCE as the reference electrode, Pt as the counter electrode). During the test, ACh was drop-wise added to the buffer solution 8 until the target concentration. The solution was then stirred for 30 seconds before the measurement. The response to ACh was evaluated in terms of current variation, Δi=ic-i0, where, ic is the observed current at the set concentration and i0 is the baseline current in the absence of substrate.
The sensitivity towards ACh was obtained from the slope, b (µA mM -1 ), of the calibration curve and was referred to the total surface area, A (cm 2 ), of the electrode as:
=
The electrodes performance was also tested by cyclic voltammetry at a scan rate of 50 mV s -1
in the presence and absence of ACh. The tests were performed both in the presence and absence of oxygen. In the latter case, nitrogen was purged in the electrolyte for 15 min before the test.
For the case of the enzymatic electrode, the affinity towards ACh was estimated in terms of the apparent Michaelis-Menten constant (Km app ). This was calculated by using the electrochemical version of the Lineweaver-Burk equation of enzyme kinetics, as previously described (du Toit and Di Lorenzo 2014b):
Where i is the steady-state current observed after the addition of glucose; imax is the maximum current under the saturated concentration of glucose; c is the ACh concentration.
Fuel cell fabrication and operation
The single-chamber membrane-less hybrid EFC used in this work was fabricated in PDMS from a 3D printed mould, as previously described (du Toit et al. 2016) . The device consisted of a 9 single chamber of 6 mm x 1 mm x 17 mm, hosting a AChE/hPG/Pt wire (the anode) and a Pt wire (as a combined counter/reference electrode), placed parallel to each other following the direction of flow. Each electrode was 10 mm long, with a total surface area exposed to the channel of 0.16 cm 2 .
The inlet and outlet streams of the device were connected to a programmable multichannel peristaltic pump (Gilson, Miniplus 3), equipped with 2-stopped pump tubing. The device was continuously fed with an aerated PBS solution containing ACh (range: 2-2400 g mL -1 ) at a rate of 0.4 ml min -1 . During the operation, the electrodes were connected to an external circuit with an external fixed resistance (Rext) of 80 kΩ and to a PicoLog ADC-24 multichannel data logger to monitor the cell voltage (V). The current output (I) was calculated using Ohm's law (I=V/ Rext) and the power was calculated as P= VI. Figure 1 shows the principle of operation of the AChE fuel cell. The hPG/Pt electrode also showed good reactivity towards ACh, with an oxidation peak at 0.27 V (vs. SCE) (Figure 2A ), which might be related to the oxidation of phosphate (du Toit and Di Lorenzo 2014a). To investigate this further, and study the interference of phosphate in the electrochemical measurements, these tests were repeated in glycine buffer ( Figure 2B and 2C ).
In the case of the AChE/hPG/Pt electrode, the oxidation peak at 0.30 V was confirmed. The response to ACh was, however, approximately two times higher than in buffer, with a ΔI≈ 0.04 mA. Moreover, the intensity of the peak produced by hPG/Pt in glycine, was of only 0.01 mA.
This value is 20% lower than the case of PBS, thus confirming the interference of phosphate.
The two peaks observed in the SWV curves, probably related to oxidation reactions occurring onto the hPG surface, might have been masked in the case of PBS by the much larger peak related to phosphate oxidation. 
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The response of both the enzymatic and non-enzymatic electrode to increasing ACh concentrations was subsequently tested by SWV and CA (at 0.3 V vs SCE). The results are reported in Figure 3 . Both electrodes showed a very good response to ACh, and generated an output current signal proportional to its concentration. Considering its high reactivity, the response of hPG/Pt to ACh was not surprising (du Toit and Di Lorenzo 2014a). Although the electrocatalytic oxidation of ACh on nanostructured electrodes has already been shown (Sattarahmady et al. 2013) , this is the first time that it is proven also for the case of porous gold.
The type of buffer used had an influence on the response. Generally, in glycine the current generated by AChE/hPG/Pt was higher than hPG/Pt ( Figure 3B and 3E), since there was no interference with phosphate in the reading. On the other hand, hPG/Pt generated a higher ( Figure   3C ) or very similar ( Figure 3F ) current than the enzymatic electrode in PBS. Although the response to ACh and the shape of the calibration curves obtained with the two types of electrodes are very similar, the process occurring in each case is very different. In the case of AChE/hPG/Pt, choline is enzymatically generated (Step 1, Figure 1 ) and then oxidized by hPG (Step 2, Figure 1 ). In the other case, ACh is directly oxidized by hPG. To confirm this hypothesis, CV tests in the presence and absence of oxygen were performed ( Figure 4 ). As shown, in the absence of oxygen AChE/hPG/Pt performs better, with a shift of approximately 0.06 mA. This is because Step 1 is favoured by the absence of oxygen. On the other hand, when hPG/Pt was operated in the absence of oxygen no response to ACh was observed, with a flat CV. Considering the instability, cost and short lifetime of enzymes, a non-enzymatic sensor would be preferred. Nonetheless, enzymes are highly selective towards the target analyte. hPG is reactive to a number of compounds found in physiological fluids, such as sugars (du Toit and Di Lorenzo 2014a), and consequently a non-enzymatic hPG sensor would suffer from very poor selectivity. Practical applications of the hPG/Pt electrode would, therefore, necessarily imply the combined use of a functional membrane that filters out interfering compounds. This might prove difficult when these impurities have a molecular weight very close to ACh, such as glucose. We therefore focused on the enzymatic electrode only. Table 1 summarizes the performance of AChE/hPG/Pt in both glycine and PBS resulting from the CA tests and Figure S1 A and B in the supplementary data show the relative calibration curves obtained. As reported, in the case of glycine buffer, the sensitivity was almost two times higher than the case of PBS, with a value of 3.04 μA mM -1 cm -2 , which corresponds to a slope of the calibration curve of approximately 0.5 μA mM -1 . This sensitivity is comparable to the values observed for other AChE electrodes found in previous works: 0.49 μA mM -1 (Sen et al. 2004) , and 0.42 μA mM -1 (Doretti et al. 2000) and it is much higher than the sensitivity of a Cunanoparticle modified electrode with a sensitivity of only 0.23 μA mM -1 cm -2 (Heli et al. 2009 ).
On the other hand, a much higher sensitivity has been recently reported with a non enzymatic metal oxide nanostructure (Sattarahmady et al. 2013 ).
In the case of the non-enzymatic hPG/Pt electrode, the sensitivity is slightly higher, 4.6 μA mM -1 cm -2 , and also the linearity range is improved (Table 1S in the supplementary data).
From the reciprocal of the current -reciprocal of ACh concentration plot ( Figure S3 and S4), it resulted a value of the apparent affinity, Km app , equal to 0.3 mM, which is in agreement with previous findings on AChE immobilised onto porous gold structures (Shulga et al. 2007 ). This is a value much lower than previously reported (Doretti et al. 2000; Sen et al. 2004) , thus demonstrating the high affinity of AChE/hPG/Pt towards ACh. 
PBS Glycine
Linearity range (mM) 0.24-1.9 0.12-1.4 Figure   5B ). It is expected that AChE/hPG/Pt is the limiting electrode in the fuel cell. Considering the effect that oxygen has on the performance of this electrode, as shown in Figure 4A , the very low current densities obtained could also be due to the saturating concentration of oxygen in the feeding solution used in this study (0.2 mM). It should be noted, however, that physiological fluids, such as plasma, present much lower oxygen concentrations and could therefore be associated with improved performance of the fuel cell (Falk et al. 2012 ).
Sensitivity
The power curves also show a good correlation between power output and ACh concentration ( Figure 5A ). The maximum power was of 4 nW at a voltage of 260 mV and for a current density of 9 μA cm -2 (ACh concentration: 10 mM). Since this is the first ACh/oxygen fuel cell reported, it is difficult to make a direct comparison on performance with other biological fuel cell devices reported in the literature, which are characterised by different device designs and catalyst used.
Nonetheless, the performance of the ACh/O2 hybrid fuel cell in terms of power output, is very similar to other biological fuel cells reported (Falk et al. 2013; Falk et al. 2012) .
Although the power output is very low, the fuel cell showed an excellent response to varying acetylcholine concentrations, thus demonstrating its remarkable potential for use as a selfpowered ACh sensor.
In Figure 5C a calibration curve is reported, obtained by connecting the two electrodes to an external resistor of 80 kΩ and varying the concentration of ACh in the feeding solution every 15 min. The response time, calculated as the time to reach 95% of the final, was in the range of 2.8-3.7 min, being lower for higher ACh concentrations. This is a much faster response than other AChE-based sensors previously reported (Doretti et al. 2000; Schuvailo et al.) .
The sensitivity of the sensor is of 0.1 μA mM -1 cm -2 , with a lower detection limit of 10 μM.
This detection limit is in the range of ACh concentrations in healthy individuals, but still too high for patients affected by AD, characterised by ACh values of 1 -6 μM (Chauhan and Pundir 2011) . Still, these preliminary results are highly encouraging, and future research will necessarily have to focus on improving the fuel cell design and on maximising the electrode surface-area-to-volume ratio to enhance both the sensitivity and the limits of detection. The fuel cell sensor showed high reproducibility, as demonstrated by the very small variation among several replicates reported in Figure 5C . Although the lifetime of the device was not tested, the hybrid fuel cell here proposed is expected to be stable for at least two days of continuous operation, according to our previous findings with a glucose/oxygen EFC having a similar set-up (du Toit and Di Lorenzo 2015). In addition, compared to this previous study where the laccase electrode was supposed to be the major limiting factor for the system stability, the use of a Pt cathode in the hybrid fuel cell might contribute to a substantial enhancement in the system lifetime (Ivanov et al. 2010) . Finally, preliminary studies have demonstrated that the immobilization of AChE onto porous structures help to increase its overall stability (Shulga et al. 2007; Sotiropoulou et al. 2005) .
CONCLUDING REMARKS
The development of rapid and low cost sensing devices for in situ monitoring of acetylcholine in plasma is key to enhance the therapy of the Alzheimer's disease. In patients affected by this serious neuro-degeneration, the levels of the neurotransmitter acetylcholine can drop by up to 90%. The consequence is a progressive and significant loss of cognitive and behavioural function. Effective in vivo monitoring of ACh can help with: timely diagnosis; monitoring treatment effectiveness; and developments of new medicines.
Current methodologies for ACh detection are mainly based on microdialysis coupled with offline analysis, and are expensive, slow and not suitable for in situ monitoring.
EFCs can provide an attractive alternative. In this study, we report the first acetylcholine/oxygen fuel cell and show an excellent response to ACh concentrations, in terms of both current and power output. No sample treatment is required and the response time is as fast as 3 min. As such, this research represents an important step towards self-powered low cost devices for the real time monitoring of ACh.
